Search results for "endothelial cells"

showing 10 items of 441 documents

CD133 expression in placenta chorioangioma presenting as a giant asymptomatic mass

2021

Background: Placental chorioangioma is the most common benign non-trophoblastic neoplasm of the placenta. Its clinical relevance lies in the size of the tumor since larger masses cause pregnancy complications, including an unfavorable neonatal outcome. Case presentation: We report the case of a 34-year-old second gravida and nullipara at the 35th week of gestation, admitted to the gynecological department for antibiotic-resistant fever. The cardiotocography performed during hospitalization showed an abnormal fetal pattern. A 2250 g newborn was delivered by cesarean section. No complications were observed during childbirth and postpartum was insignificant. On gross inspection a white fleshy …

CD31Adultmedicine.medical_specialtyMedicine (General)Placenta Diseasesgiant asymptomatic maPlacentaCase Reportgiant asymptomatic massR5-920PregnancyPlacentamedicineChildbirthCD133 expression; Giant asymptomatic mass; Placental chorioangioma; Adult; Cesarean Section; Endothelial Cells; Female; Humans; Infant Newborn; Placenta; Pregnancy; Hemangioma; Placenta Diseases; Pregnancy Complications NeoplasticHumansClinical significanceCardiotocographyGiant asymptomatic massPregnancyFetusNeoplasticplacental chorioangiomamedicine.diagnostic_testObstetricsbusiness.industryCesarean SectionCD133 expression; Giant asymptomatic mass; Placental chorioangiomaEndothelial CellsInfantGeneral Medicinemedicine.diseaseNewbornPregnancy Complicationsmedicine.anatomical_structurePlacental chorioangiomaembryonic structuresGestationFemaleGiant asymptomatic mabusinessHemangiomaCD133 expression
researchProduct

Implanted neonatal human dermal fibroblasts influence the recruitment of endothelial cells in mice

2012

The vascularization of new tissue within a reasonable time is a crucial prerequisite for the success of different cell- and material-based strategies. Considering that angiogenesis is a multi-step process involving humoral and cellular regulatory components, only in vivo assays provide the adequate information about vessel formation and the recruitment of endothelial cells. The present study aimed to investigate if neonatal human dermal fibroblasts could influence in vivo neovascularization. Results obtained showed that fibroblasts were able to recruit endothelial cells to vascularize the implanted matrix, which was further colonized by murine functional blood vessels after one week. The ve…

CD31MalePathologymedicine.medical_specialtyAngiogenesisCell TransplantationBiomedical EngineeringCD34Medicine (miscellaneous)Neovascularization PhysiologicInflammationAntigens CD34BiologyNitric OxideRegenerative MedicineBiomaterialsNeovascularizationHemoglobinsMiceTissue engineeringMicroscopy Electron TransmissionIn vivoReportmedicineAnimalsHumansRegenerationSkinInflammationMatrigelNeovascularization PathologicTissue EngineeringEndothelial CellsGeneral MedicineFibroblastsMice Inbred C57BLPlatelet Endothelial Cell Adhesion Molecule-1Drug CombinationsPhenotypeProteoglycansCollagenLamininmedicine.symptom
researchProduct

The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on p…

2008

Angiogenesis is a key element in early wound healing and is considered important for tissue regeneration and for directing inflammatory cells to the wound site. The improvement of vascularization by implementation of endothelial cells or angiogenic growth factors may represent a key solution for engineering bone constructs of large size. In this study, we describe a long-term culture environment that supports the survival, proliferation, and in vitro vasculogenesis of human umbilical vein endothelial cells (HUVEC). This condition can be achieved in a co-culture model of HUVEC and primary human osteoblasts (hOB) employing polyurethane scaffolds and platelet-rich plasma in a static microenvir…

CD31Umbilical VeinsTime FactorsMaterials scienceAngiogenesisCellular differentiationPolyurethanesBiophysicsFluorescent Antibody TechniqueNeovascularization PhysiologicBioengineeringUmbilical veinBiomaterialsVasculogenesismedicineHumansCells CulturedCell ProliferationMicroscopy ConfocalOsteoblastsTissue ScaffoldsReverse Transcriptase Polymerase Chain ReactionEndothelial CellsOsteoblastCoculture TechniquesCell biologyEndothelial stem cellPhenotypemedicine.anatomical_structureGene Expression RegulationMechanics of MaterialsImmunologycardiovascular systemCeramics and CompositesWound healingBiomarkersBiomaterials
researchProduct

Impaired in vivo vasculogenic potential of endothelial progenitor cells in comparison to human umbilical vein endothelial cells in a spheroid-based i…

2009

Objectives:  Neovascularization represents a major challenge in tissue engineering applications since implantation of voluminous grafts without sufficient vascularity results in hypoxic cell death of implanted cells. An attractive therapeutic approach to overcome this is based on co-implantation of endothelial cells to create vascular networks. We have investigated the potential of human endothelial progenitor cells (EPC) to form functional blood vessels in vivo in direct comparison to vascular-derived endothelial cells, represented by human umbilical vein endothelial cells (HUVEC). Materials and methods:  EPCs were isolated from human peripheral blood, expanded in vitro and analysed in vit…

CD31Umbilical VeinsTransplantation HeterologousNeovascularization PhysiologicMice SCIDBiologyUmbilical veinNeovascularizationMiceVasculogenesisTissue engineeringSpheroids CellularmedicineAnimalsHumansProgenitor cellCells CulturedMatrigelTissue EngineeringStem CellsEndothelial CellsCell BiologyGeneral MedicineOriginal ArticlesCell biologyTransplantationPhenotypeImmunologyembryonic structurescardiovascular systemmedicine.symptomStem Cell TransplantationCell proliferation
researchProduct

Paracrine Effects Influenced by Cell Culture Medium and Consequences on Microvessel-Like Structures in Cocultures of Mesenchymal Stem Cells and Outgr…

2011

Mesenchymal stem cells (MSC) from bone marrow and outgrowth endothelial cells (OEC) from peripheral blood are considered as attractive cell types for applications in regenerative medicine aiming to build up complex vascularized tissue-engineered constructs. MSC provide several advantages such as the potential to differentiate to osteoblasts and to support the neovascularization process by release of proangiogenic factors. On the other hand, the neovascularization process can be actively supported by OEC forming perfused vascular structures after co-implantation with other cell types. In this study the formation of angiogenic structures in vitro was investigated in cocultures of MSC and OEC,…

CD31medicine.medical_treatmentCellular differentiationBiomedical EngineeringFluorescent Antibody TechniqueEnzyme-Linked Immunosorbent AssayBioengineeringCD146 AntigenBiologyPolymerase Chain ReactionBiochemistryBiomaterialsParacrine signallingchemistry.chemical_compoundmedicineHumansCells CulturedGrowth factorMesenchymal stem cellEndothelial CellsCell DifferentiationMesenchymal Stem CellsFlow CytometryCoculture TechniquesCulture MediaCell biologyPlatelet Endothelial Cell Adhesion Molecule-1Vascular endothelial growth factorchemistryCell cultureImmunologyCD146Tissue Engineering Part A
researchProduct

Meox2/Tcf15 Heterodimers Program the Heart Capillary Endothelium for Cardiac Fatty Acid Uptake

2015

Background— Microvascular endothelium in different organs is specialized to fulfill the particular needs of parenchymal cells. However, specific information about heart capillary endothelial cells (ECs) is lacking. Methods and Results— Using microarray profiling on freshly isolated ECs from heart, brain, and liver, we revealed a genetic signature for microvascular heart ECs and identified Meox2/Tcf15 heterodimers as novel transcriptional determinants. This signature was largely shared with skeletal muscle and adipose tissue endothelium and was enriched in genes encoding fatty acid (FA) transport–related proteins. Using gain- and loss-of-function approaches, we showed that Meox2/Tcf15 media…

CD36 AntigensHeterozygoteEndotheliumCD36Cardiac Output LowAdipose tissueLipoproteins VLDLBiologyFatty Acid-Binding ProteinsMicePhysiology (medical)Protein Interaction MappingBasic Helix-Loop-Helix Transcription FactorsmedicineAnimalsHumansRNA Small InterferingTranscription factorCells CulturedHomeodomain Proteinschemistry.chemical_classificationLipoprotein lipaseMyocardiumFatty AcidsEndothelial CellsFatty acidSkeletal muscleMetabolismCoronary VesselsCell biologyMice Inbred C57BLLipoprotein LipaseGlucosemedicine.anatomical_structureAdipose TissuechemistryBiochemistryTissue Array Analysisbiology.proteinTranscriptomeCardiology and Cardiovascular MedicineCirculation
researchProduct

Murine liver antigen presenting cells control suppressor activity of CD4+CD25+ regulatory T cells.

2005

CD4(+)CD25(+) regulatory T cells (Treg) are important mediators of peripheral immune tolerance; however, whether Treg participate also in hepatic immune tolerance is not clear. Therefore, we tested the potential of Treg to suppress stimulation of CD4(+) T cells by liver sinusoidal endothelial cells (LSEC), Kupffer cells (KC), or hepatocytes. In the absence of Treg, all 3 types of liver cells could stimulate CD4(+) T cell proliferation; in the presence of Treg, however, CD4(+) T cell proliferation was suppressed. Interaction with KC even stimulated the expansion of the Treg population; LSEC or hepatocytes, in contrast, could not induce proliferation of Treg. Because liver inflammation can be…

CD4-Positive T-LymphocytesLiver cytologyKupffer CellsT cellT-LymphocytesAntigen-Presenting Cellschemical and pharmacologic phenomenaBiologyImmune toleranceMiceAntigenmedicineImmune ToleranceAnimalsIL-2 receptorAntigen-presenting cellCell ProliferationInflammationHepatologyLiver cellKupffer cellEndothelial Cellshemic and immune systemsReceptors Interleukin-2medicine.anatomical_structureLiverImmunologyCancer researchHepatocytesHepatology (Baltimore, Md.)
researchProduct

Biocompatibility studies of endothelial cells on a novel calcium phosphate/SiO 2 -xerogel composite for bone tissue engineering

2008

The bone biomaterial BONITmatrix®, a nanoporous, granular scaffold composed of hydroxylapatite, calcium phosphate and SiO2, linked by a dense collagen mesh, was tested for its biocompatibility using endothelial cells (EC) in the form of macrovascular HUVEC, microvascular HDMEC and the endothelial cell line ISOHAS-1. Cells were examined for their adherence and growth on the biomaterial and this was followed by confocal laser scanning microscopy after vital staining or immunocytochemical reactions, as well as by scanning electron microscopy. Macro- and microvascular ECs predominantly spread on BONITmatrix®-collagen mesh-covered surfaces and fibres and maintained their typical morphology. As E…

Calcium PhosphatesMaterials scienceBiocompatibilityCell SurvivalBiomedical Engineeringchemistry.chemical_elementBioengineeringCalciumBiomaterialschemistry.chemical_compoundTissue engineeringIn vivoMaterials TestingHumansCells CulturedCell ProliferationTissue EngineeringEndothelial CellsBiomaterialHydroxylapatiteSilicon DioxideIn vitroEndothelial stem cellchemistryBone SubstitutesBiophysicsGelsBiomedical engineeringBiomedical Materials
researchProduct

Microstructure, mechanical characteristics and cell compatibility of β-tricalcium phosphate reinforced with biodegradable Fe–Mg metal phase

2015

The use of beta-tricalcium phosphate (β-TCP) ceramic as a bioresorbable bone substitute is limited to non-load-bearing sites by the material׳s brittleness and low bending strength. In the present work, new biocompatible β-TCP-based composites with improved mechanical properties were developed via reinforcing the ceramic matrix with 30 vol% of a biodegradable iron-magnesium metallic phase. β-TCP-15Fe15Mg and β-TCP-24Fe6Mg (vol%) composites were fabricated using a combination of high energy attrition milling, cold sintering/high pressure consolidation of powders at room temperature and annealing at 400 °C. The materials synthesized had a hierarchical nanocomposite structure with a nanocrystal…

Calcium PhosphatesMaterials scienceIronComposite numberBiomedical EngineeringSinteringBiocompatible Materials02 engineering and technology010402 general chemistryCeramic matrix composite01 natural sciencesCell LineBiomaterialsFlexural strengthMaterials TestingHumansMagnesiumCeramicComposite materialMechanical PhenomenaOsteoblastsNanocompositeEndothelial Cells021001 nanoscience & nanotechnologyMicrostructureNanocrystalline material0104 chemical sciencesMechanics of Materialsvisual_artvisual_art.visual_art_medium0210 nano-technologyJournal of the Mechanical Behavior of Biomedical Materials
researchProduct

CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA

2015

Background CD90+ liver cancer cells have been described as cancer stem-cell-like (CSC), displaying aggressive and metastatic phenotype. Using two different in vitro models, already described as CD90+ liver cancer stem cells, our aim was to study their interaction with endothelial cells mediated by the release of exosomes. Methods Exosomes were isolated and characterized from both liver CD90+ cells and hepatoma cell lines. Endothelial cells were treated with exosomes, as well as transfected with a plasmid containing the full length sequence of the long non-coding RNA (lncRNA) H19. Molecular and functional analyses were done to characterize the endothelial phenotype after treatments. Results …

Cancer ResearchAngiogenesisAngiogenesis; CD90+ liver cancer cells; Exosomes; Long-non-coding RNA H19; Antigens Thy-1; Cell Adhesion; Cell Line Tumor; Endothelial Cells; Exosomes; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; RNA Long Noncoding; Phenotype; Molecular Medicine; Oncology; Cancer ResearchBiologyCD90+ liver cancer cellsExosomesCell LineSettore BIO/13 - Biologia ApplicataCancer stem cellCell Line TumormedicineCell AdhesionHuman Umbilical Vein Endothelial CellsHumansCD90AntigensThy-1TumorExosomes Long-non-coding RNA H19 CD90+ liver cancer cells AngiogenesisResearchLiver NeoplasmsCancerEndothelial Cellsmedicine.diseaseMicrovesiclesCell biologyEndothelial stem cellPhenotypeOncologyembryonic structuresThy-1 AntigensRNAMolecular MedicineRNA Long NoncodingLong NoncodingAngiogenesisStem cellLiver cancerLong-non-coding RNA H19Molecular Cancer
researchProduct